9 trials newly registered in Blood and Lymph Conditions, first posted 2026-10-22, by therapeutic area, largest first. All areas.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-Interventional Study of Ranicabtagene Autoleucel Injection for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma Ranicabtagene Autoleucel Injection - B-Cell Non-Hodgkin Lymphoma (NHL) | Not yet recruiting | Hrain Biotechnology Co., Ltd. | 200 | 2026-10-30 | 2026-10-22 | |
| Comparing Bispecific Antibody Treatment to Autologous Stem Cell Transplant for Newly Diagnosed, Standard Risk Multiple Myeloma Daratumumab and Recombinant Human Hyaluronidase, Lenalidomide, Bortezomib - Multiple Myeloma (MM) | Phase 2 / Phase 3 | Not yet recruiting | Alliance for Clinical Trials in Oncology | 920 | 2026-12-23 | 2026-10-22 |
| IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade Astrocytomas IDH1-vac, IS-vac, Temozolomide (TMZ) - Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4 | Phase 2 | Not yet recruiting | German Cancer Research Center | 216 | 2027-02-01 | 2026-10-22 |
| Impact of Telepharmacy on Hemodialysis Outcomes Routine Standard Care, Telepharmacy Intervention - Anemia, Hemodialysis | Not applicable | Completed | Damanhour University | 101 | 2024-12-01 | 2026-10-22 |
| Anakinra for Prevention of Poor Graft Function in MDS Allo-HSCT Anakinra - Poor Graft Function, Myelodysplastic Syndromes | Phase 1 / Phase 2 | Not yet recruiting | Ruijin Hospital | 66 | 2026-10-05 | 2026-10-22 |
| G-CSF In Neonatal Sepsis With Neutropenia Granulocyte-colony stimulating factor (G-CSF), Standard Sepsis Management - Neonatal Sepsis, Neutropenia | Not applicable | Not yet recruiting | University of Health Sciences Lahore | 52 | 2027-02-15 | 2026-10-22 |
| CD19 CAR-T Cell Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Phase I/II Study MB-CART19.1 - Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Hospital Universitario Dr. Jose E. Gonzalez | 30 | 2026-12-01 | 2026-10-22 |
| A Single-Arm,Multicenter Phase, Phase II Clinical Trial of Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents treated group - Histiocytosis,Langerhans-Cell | Phase 1 / Phase 2 | Enrolling by invitation | Second Affiliated Hospital of Wenzhou Medical University | 2 | 2026-10-20 | 2026-10-22 |
| Use of Reconstructive Microsurgery for the Treatment of Lymphedema Surgery with and without the aid of Indocyanine Green (ICG) - Lymphedema | Recruiting | Istituto Ortopedico Rizzoli | 15 | 2026-09-29 | 2026-10-22 |